NVDA
NVIDIA
-- 116.350 TSLA
Tesla
-- 271.660 TSM
Taiwan Semiconductor
-- 179.790 PLTR
Palantir
-- 83.090 AMD
Advanced Micro Devices
-- 99.710 
NEWS
BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer
Monday, 2nd December at 7:50 am
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell's pivotal Phase 3 study of Bria-IMT™ plus an immune check point inhibitor in metastatic breast cancer
The pivotal Phase 3 study is currently under Fast Track Designation with the Food and Drug Administration (FDA)
Monday, 2nd December at 7:50 am
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell's pivotal Phase 3 study of Bria-IMT™ plus an immune check point inhibitor in metastatic breast cancer
The pivotal Phase 3 study is currently under Fast Track Designation with the Food and Drug Administration (FDA)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment